Synthetic cannabinoid WIN 55,212-2 mesylate enhances the protective action of four classical antiepileptic drugs against maximal electroshock-induced seizures in mice

Pharmacology Biochemistry and Behavior

Volumn 98, Issue 2, 2011, Pages 261-267

  Luszczki, Jarogniew J ^a,b   Misiuta Krzesinska, Marta ^a   Florek, Magdalena ^b   Tutka, Piotr ^a   Czuczwar, Stanislaw J ^a,b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Antiepileptic drugs; Cannabinoids; Maximal electroshock induced seizures; WIN 55,212 2 mesylate

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (4 MORPHOLINYLMETHYL)PYRROLO[1,2,3 DE] 1,4 BENZOXAZIN 6 YL 1 NAPHTHALENYLMETHANONE MESYLATE; CANNABINOID; CARBAMAZEPINE; PHENOBARBITAL; PHENYTOIN; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COORDINATION DISORDER; DOSE RESPONSE; DRUG BRAIN LEVEL; DRUG EFFICACY; DRUG POTENTIATION; GRIP STRENGTH; LONG TERM MEMORY; MALE; MOUSE; MUSCLE WEAKNESS; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SEIZURE; TASK PERFORMANCE;

ANIMALS; ANTICONVULSANTS; AVOIDANCE LEARNING; BENZOXAZINES; CARBAMAZEPINE; DRUG SYNERGISM; ELECTROSHOCK; MALE; MEMORY, LONG-TERM; MICE; MORPHOLINES; MUSCLE STRENGTH; NAPHTHALENES; PHENOBARBITAL; PHENYTOIN; PSYCHOMOTOR PERFORMANCE; RECEPTORS, CANNABINOID; SEIZURES; VALPROIC ACID;

MUS;

EID: 79251642782     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2011.01.002     Document Type: Article

References (50)

1. B.E. Alger Endocannabinoids and their implications for epilepsy Epilepsy Curr 4 2004 169 173
2. A. Bahremand, S.E. Nasrabady, H. Shafaroodi, M. Ghasemi, and A.R. Dehpour Involvement of nitrergic system in the anticonvulsant effect of the cannabinoid CB(1) agonist ACEA in the pentylenetetrazole-induced seizure in mice Epilepsy Res 84 2009 110 119
3. R.E. Blair, L.S. Deshpande, S. Sombati, K.W. Falenski, B.R. Martin, and R.J. DeLorenzo Activation of the cannabinoid type-1 receptor mediates the anticonvulsant properties of cannabinoids in the hippocampal neuronal culture models of acquired epilepsy and status epilepticus J Pharmacol Exp Ther 317 2006 1072 1078 (Pubitemid 43764110)
4. W.O. Boggan, R.A. Steele, and D.X. Freedman 9-Tetrahydrocannabinol effect on audiogenic seizure susceptibility Psychopharmacologia 29 1973 101 106
5. J.R. Boissier, J. Tardy, and J.C. Diverres Une nouvelle méthode simple pour explorer laction tranquilisante: le test de la cheminée Med Exp (Basel) 3 1960 81 84
6. M.E. Corcoran, J.A. McCaughran Jr., and J.A. Wada Acute antiepileptic effects of 9-tetrahydrocannabinol in rats with kindled seizures Exp Neurol 40 1973 471 483
7. B. Cox, M. ten Ham, W.J. Loskota, and P. Lomax The anticonvulsant activity of cannabinoids in seizure sensitive gerbils Proc West Pharmacol Soc 18 1975 154 157
8. S.J. Czuczwar, and J.J. Luszczki Effect of ACEA - a highly selective cannabinoid CB1 receptor agonist on the protective action of clonazepam, ethosuximide, phenobarbital and valproate in the mouse pentylenetetrazole- induced clonic seizure model Epilepsia 50 Suppl. 11 2009 366 Abstract
9. C.L. Deckers, S.J. Czuczwar, Y.A. Hekster, A. Keyser, H. Kubova, and H. Meinardi Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed Epilepsia 41 2000 1364 1374
10. L.S. Deshpande, R.E. Blair, J.M. Ziobro, S. Sombati, B.R. Martin, and R.J. DeLorenzo Endocannabinoids block status epilepticus in cultured hippocampal neurons Eur J Pharmacol 558 2007 52 59 (Pubitemid 46328867)
11. C. Dwivedi, and R.D. Harbison Anticonvulsant activities of delta-8 and delta-9 tetrahydrocannabinol and uridine Toxicol Appl Pharmacol 31 1975 452 458
12. K.W. Falenski, R.E. Blair, L.J. Sim-Selley, B.R. Martin, and R.J. DeLorenzo Status epilepticus causes a long-lasting redistribution of hippocampal cannabinoid type 1 receptor expression and function in the rat pilocarpine model of acquired epilepsy Neuroscience 146 2007 1232 1244 (Pubitemid 46694119)
13. K.W. Falenski, D.S. Carter, A.J. Harrison, B.R. Martin, R.E. Blair, and R.J. DeLorenzo Temporal characterization of changes in hippocampal cannabinoid CB(1) receptor expression following pilocarpine-induced status epilepticus Brain Res 1262 2009 64 72
14. D.M. Feeney, H.R. Wagner, M.C. McNamara, and G. Weiss Effects of tetrahydrocannabinol on hippocampal evoked afterdischarges in cats Exp Neurol 41 1973 357 365
15. S. Gholizadeh, H. Shafaroodi, M. Ghasemi, A. Bahremand, M. Sharifzadeh, and A.R. Dehpour Ultra-low dose cannabinoid antagonist AM251 exchanges cannabinoid anticonvulsant effects in the pentylenetetrazole-induced seizure in mice Neuropharmacology 53 2007 763 770 (Pubitemid 47532147)
16. T. Hayase, Y. Yamamoto, and K. Yamamoto Protective effects of cannabinoid receptor agonists against cocaine and other convulsant-induced toxic behavioural symptoms J Pharm Pharmacol 53 2001 1525 1532 (Pubitemid 33064542)
17. D.A. Karanian, S.L. Karim, J.T. Wood, J.S. Williams, S. Lin, and A. Makriyannis Endocannabinoid enhancement protects against kainic acid-induced seizures and associated brain damage J Pharmacol Exp Ther 322 2007 1059 1066 (Pubitemid 47295815)
18. R. Karler, W. Cely, and S.A. Turkanis Anticonvulsant properties of delta 9-tetrahydrocannabinol and other cannabinoids Life Sci 15 1974 931 947
19. S. Koda, S. Takeda, H. Onimaru, S. Akada, and A. Sakamoto Cannabinoid suppressed bicuculline-induced convulsion without respiratory depression in the brainstem-spinal cord preparation from newborn rats Biomed Res 26 2005 241 247 (Pubitemid 43137331)
20. R. Kozan, M. Ayyildiz, and E. Agar The effects of intracerebroventricular AM-251, a CB1-receptor antagonist, and ACEA, a CB1-receptor agonist, on penicillin-induced epileptiform activity in rats Epilepsia 50 2009 1760 1767
21. J.T. Litchfield Jr., and F. Wilcoxon A simplified method of evaluating dose-effect experiments J Pharmacol Exp Ther 96 1949 99 113
22. W. Löscher, C.P. Fassbender, and B. Nolting The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models Epilepsy Res 8 1991 79 94
23. J.J. Luszczki, M. Swiader, M. Czuczwar, J. Kis, and S.J. Czuczwar Interactions of tiagabine with some antiepileptics in the maximal electroshock in mice Pharmacol Biochem Behav 75 2003 319 327 (Pubitemid 36859817)
24. J.J. Luszczki, M. Swiader, J. Parada-Turska, and S.J. Czuczwar Tiagabine synergistically interacts with gabapentin in the electroconvulsive threshold test in mice Neuropsychopharmacology 28 2003 1817 1830 (Pubitemid 41070847)
25. J.J. Luszczki, J. Wojcik-Cwikla, M.M. Andres, and S.J. Czuczwar Pharmacological and behavioral characteristics of interactions between vigabatrin and conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: an isobolographic analysis Neuropsychopharmacology 30 2005 958 973 (Pubitemid 40570911)
26. J.J. Luszczki, P. Czuczwar, A. Cioczek-Czuczwar, and S.J. Czuczwar Arachidonyl-2′-chloroethylamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model Eur J Pharmacol 547 2006 65 74 (Pubitemid 44373908)
27. J.J. Luszczki, N. Ratnaraj, P.N. Patsalos, and S.J. Czuczwar Isobolographic analysis of interactions between loreclezole and conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model Naunyn Schmiedebergs Arch Pharmacol 373 2006 169 181 (Pubitemid 43742442)
28. J.J. Luszczki, L. Antkiewicz-Michaluk, and S.J. Czuczwar Isobolographic analysis of interactions between 1-methyl-1, 2, 3, 4-tetrahydroisoquinoline and four conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model Eur J Pharmacol 602 2009 298 305
29. J.J. Luszczki, P. Czuczwar, A. Cioczek-Czuczwar, M. Dudra-Jastrzebska, M. Andres-Mach, and S.J. Czuczwar Effect of arachidonyl-2′-chloroethylamide, a selective cannabinoid CB1 receptor agonist, on the protective action of the various antiepileptic drugs in the mouse maximal electroshock-induced seizure model Prog Neuropsychopharmacol Biol Psychiatry 34 2010 18 25
30. B. Lutz On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures Biochem Pharmacol 68 2004 1691 1698 (Pubitemid 39278491)
31. J.A. McCaughran Jr., M.E. Corcoran, and J.A. Wada Anticonvulsant activity of delta-8- and delta-9-tetrahydrocannabinol in rats Pharmacol Biochem Behav 2 1974 227 233
32. B.S. Meldrum, R.G. Fariello, E.A. Puil, M. Derouaux, and R. Naquet Delta9-tetrahydrocannabinol and epilepsy in the photosensitive baboon, Papio papio Epilepsia 15 1974 255 264
33. O.A. Meyer, H.A. Tilson, W.C. Byrd, and M.T. Riley A method for the routine assessment of fore- and hindlimb grip strength of rats and mice Neurobehav Toxicol 1 1979 233 236 (Pubitemid 11204691)
34. K. Monory, F. Massa, M. Egertová, M. Eder, H. Blaudzun, and R. Westenbroek The endocannabinoid system controls key epileptogenic circuits in the hippocampus Neuron 51 2006 455 466 (Pubitemid 44209321)
35. N. Naderi, F. Aziz Ahari, B. Shafaghi, A.H. Najarkolaei, and F. Motamedi Evaluation of interactions between cannabinoid compounds and diazepam in electroshock-induced seizure model in mice J Neural Transm 115 2008 1501 1511
36. V. Rizzo, G. Ferraro, F. Carletti, G. Lonobile, C. Cannizzaro, and P. Sardo Evidences of cannabinoids-induced modulation of paroxysmal events in an experimental model of partial epilepsy in the rat Neurosci Lett 462 2009 135 139
37. A. Romigi, M. Bari, F. Placidi, M.G. Marciani, M. Malaponti, and F. Torelli Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy Epilepsia 51 2010 768 772
38. H. Shafaroodi, M. Samini, L. Moezi, H. Homayoun, H. Sadeghipour, and S. Tavakoli The interaction of cannabinoids and opioids on pentylenetetrazole- induced seizure threshold in mice Neuropharmacology 47 2004 390 400 (Pubitemid 38953230)
39. A.H. Sheerin, X. Zhang, D.M. Saucier, and M.E. Corcoran Selective antiepileptic effects of N-palmitoylethanolamide, a putative endocannabinoid Epilepsia 45 2004 1184 1188 (Pubitemid 39350330)
40. M. Shen, and S.A. Thayer The cannabinoid agonist WIN 55,212-2 inhibits calcium channels by receptor-mediated and direct pathways in cultured rat hippocampal neurons Brain Res 783 1998 77 84 (Pubitemid 28131424)
41. M. Shen, and S.A. Thayer Delta9-tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture Mol Pharmacol 55 1999 8 13 (Pubitemid 29042516)
42. P.F. Smith Cannabinoids as potential anti-epileptic drugs Curr Opin Investig Drugs 6 2005 680 685 (Pubitemid 40904038)
43. L.J. Stephen, and M.J. Brodie Seizure freedom with more than one antiepileptic drug Seizure 11 2002 349 351 (Pubitemid 35154146)
44. M. Ten Ham, W.J. Loskota, and P. Lomax Acute and chronic effects of beta9-tetrahydrocannabinol on seizures in the gerbil Eur J Pharmacol 31 1975 148 152
45. P. Venault, G. Chapouthier, L.P. de Carvalho, J. Simiand, M. Morre, and R.H. Dodd Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks Nature 321 1986 864 866 (Pubitemid 16097728)
46. J.A. Wada, M. Sato, and M.E. Corcoran Antiepileptic properties of 9-tetrahydrocannabinol Exp Neurol 39 1973 157 165
47. M.J. Wallace, J.L. Wiley, B.R. Martin, and R.J. DeLorenzo Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects Eur J Pharmacol 428 2001 51 57 (Pubitemid 32971757)
48. M.J. Wallace, B.R. Martin, and R.J. DeLorenzo Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity Eur J Pharmacol 452 2002 295 301 (Pubitemid 35279432)
49. M.J. Wallace, R.E. Blair, K.W. Falenski, B.R. Martin, and R.J. DeLorenzo The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy J Pharmacol Exp Ther 307 2003 129 137 (Pubitemid 37151898)
50. A. Zadrozniak, E. Wojda, A. Wlaz, and J.J. Luszczki Characterization of acute adverse-effect profiles of selected antiepileptic drugs in the grip-strength test in mice Pharmacol Rep 61 2009 737 742